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Abstract Concerns regarding the presence of drug residues
in foods include allergic reactions, toxicity, technological
problems in fermented products and the development of
antibiotic resistance in human pathogens. The analysis of
antimicrobial residues in foods is generally carried out, in a
first step, through microbiological screening tests. These
tests commonly use Geobacillus stearothermophilus as
target specie but show a low ability to detect quinolones.
The goal of our study was to evaluate the performance of a
new microbiological test (Equinox) for detection of
quinolone residues in muscle. The kit contains an ampoule
with a standardized number of freeze-dried Escherichia coli
and must be diluted with a specific detection medium
containing a redox indicator. Microbial growth will modify
the redox potential of the medium being observed through a
colour change (from blue to brown/orange). Equinox limits
of detection for most of tested quinolones (enrofloxacin,
norfloxacin, sarafloxacin, marbofloxacin, ciprofloxacin,
danofloxacin and difloxacin) were below or around
maximum residue limit (MRL) UE and CCβ values
obtained corresponded with the determined sensitivities.
In contrast, flumequine could not be detected at MRL UE
levels. Moreover, Equinox displayed a low sensitivity to
other antimicrobials. Sensitivity data obtained in vitro were
consistent when testing incurred muscle samples. Matrix
constituents, test batch and animal species did not affect the
performance of the test. Equinox could be easily automated
enabling a large numbers of simultaneous analysis, and a
photometric reading can be applied for a precise interpre-
tation. The results obtained in this study prove that Equinox
is a useful tool when screening for quinolone residues or
can be combinedwith other methods for screening of unknown
samples.
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Introduction
The use of antimicrobials such as antibiotics and sulpho-
namides is a common practice in livestock. The adminis-
tration of these drugs may lead to the presence of violative
levels of antimicrobial residues in edible products from
animals (Anonymous 1990).
Several concerns regarding the presence of drug residues
in foods are technological problems in fermented products,
toxicity and potential allergic reactions in sensitized
individuals (Mäyra-Mäkinen 1995; Cerny 1996; Demoly
and Romano 2005). However, the selection of resistant
bacteria in farm animals and the subsequent transfer of
resistance genes is generally considered as the main risk
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derived from the use of antimicrobials in farm animals
(Levy 1998; EMEA 1999; WHO 2001). Thus, there is a
requirement for rapid, simple and cost-effective tests to
screen food of animal origin for the presence of antimicrobial
drug residues.
Since antimicrobials do not share a common chemical
structure, different analytical procedures are needed to
detect every family or even each single compound.
Therefore, in a first level, the control of antimicrobials in
foods is usually performed by using screening tests—
generally, microbiological tests—which should distinguish
samples that contain or may contain illegal levels of
antimicrobial residues from samples not containing such
residues. These tests are relatively cheap and easy to
perform and they have a broad spectrum of sensitivity.
Microbial screening tests are based on a bacterial growth
inhibition produced by concentrations of residues above the
detection limit of the test. Most of these tests use
Geobacillus stearothermophilus as an indicator strain.
However, screening tests employing this microorganism
are not able to detect quinolones at violative levels in foods
because of their poor sensitivity to these antimicrobial
compounds (Cullor 1992; Suhren and Heeschen 1996).
Consequently, additional testing is required to ensure that
the whole antibiotic spectrum is adequately covered.
Quinolones are a group of synthetic antibiotics with both
human and veterinary medical uses. These antibacterials are
widely used in livestock and fish farm industries (Fàbrega
et al. 2008). Quinolones inhibit DNA synthesis by
promoting cleavage of bacterial DNA in the DNA-enzyme
complexes of DNA gyrase and type IV topoisomerase,
resulting in rapid bacterial death (Hawkey 2003; Hoshino et
al. 1994; Hooper and Wolfson 1993).
Analytical methods described in the literature for the
analysis of quinolones in foods include instrumental techni-
ques (Hernández-Arteseros et al. 1998; Rose et al. 1998;
Roybal et al. 2002), rapid immunological techniques
(Tittlemier et al. 2008; Scortichini et al. 2009) and microbial
methods (Currie et al. 1998; Pikkemaat et al. 2007; Fuselier
et al. 2000; Calderón et al. 1996; Myllyniemi et al. 2001;
Cantwell and O'keeffe 2006; Gaudin et al. 2009).
Instrumental and immunological techniques provide infor-
mation on the identities and concentrations of quinolones
residues in foods. Nevertheless, these techniques are usually
expensive, technically complicated and time-consuming.
Thus, they are not suitable when screening a large numbers
of samples and microbial multiplate screening methods are
widely used for this purpose. These microbial methods usually
include a plate seeded with Escherichia coli able to detect
quinolones residues in foods. Although these tests are simple
they are usually time-consuming and could exhibit wide
variations in the performance between laboratories (Stead et
al. 2004)
A new kit test for quinolones detection in several food
matrices (Equinox) recently became available. The kit contains
an ampoule with a standardized number of freeze-dried E. coli
ATCC 11303. Prior to the analysis, the ampoule must be
diluted with a specific detection medium containing a redox
indicator. The assay is carried out in microwells: bacterial
cells will multiply throughout incubation time (37°C) in
absence of quinolone residues above the detection limit of the
test. This microbial growth will modify the redox potential of
the medium and can be observed through a colour change in
the medium (from blue to brown/orange). A photometric
reading can also be applied for a more accurate interpretation
of results. On the other hand, concentrations of residues able
to inhibit the growth of E. coli will prevent the indicator
changing to brown/orange.
The goal of our study was to evaluate the performance of a
Equinox test for detection of quinolone residues in muscle.
Materials and Methods
Antibiotic Standards
For preparation of antibiotic and sulphonamide stock
solutions, drug standards of known purity with certificates
of analysis were purchased from Sigma-Aldrich (Steinheim,
Germany) except enrofloxacin, ciprofloxacin (Fluka,
Buchs, Switzerland) and sarafloxacin, marbofloxacin, dano-
floxacin and difloxacin (Riedel-de Haën, Seelze, Germany).
Stock solutions were prepared at a concentration of 1 mg ml-1
using distilled water (doxycycline, tylosin, neomycin,
penicillin G, sulfathiazole), acetic acid 5% (enrofloxacin),
sodium hydroxide 1 M (ciprofloxacin, marbofloxacin,
danofloxacin, difloxacin and flumequine), sodium hydroxide
0.5 M (sarafloxacin) and glacial acetic acid (norfloxacin).
These stock solutions were kept at −20°C for a maximum of
2 months and diluted in distilled water to concentrations
suitable for preparation of the spiked samples.
Sample Preparation
Meat samples (bovine/ovine/porcine) were purchased from
retail outlets in Zaragoza (Spain) and were tested with a
combination of two inhibition tests: STAR protocol
(Fuselier et al. 2000) and Explorer kit (ZEU-Inmunotec,
Zaragoza, Spain). All samples were inhibitor-negative.
Blank tissue fluid was obtained from fore rib muscle
(bovine), leg (ovine) and loin (porcine). A piece of muscle
(2–3 g) was cut and placed in a heat-resistant plastic tube
and a heating was carried out in a water bath at 100°C for
3 min. Blank tissue fluid was collected and clarified by
centrifugation (2,000×g for 3 min) and it was kept at −20°C
for a maximum of 1 month. Most assays were performed
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using bovine tissue fluid while ovine and porcine were
utilized for ruggedness testing.
Test Procedure
Equinox test includes vials containing freeze-dried E. coli,
vials with Q medium (detection medium with a redox
indicator) and plastic microwells. The freeze-dried E. coli
must be reconstituted with the medium.
The assay was carried on microwells, mixing gently
50 uL of sample or control with 200 uL of reconstituted
E. coli. Non-spiked tissue fluid was used as blank sample.
The wells were covered with foil and incubated at 37±1°C
until blank samples had turned brown-orange. At that time
(approximately 18–20 h) the wells were examined and a
photometric reading was performed.
Readings and Interpretation of the Equinox Results
Equinox results were evaluated both with a visual reading
and a photometric measurement. When a visual reading
was applied, the wells were held at eye level: blue wells
were considered as positive results while brown or orange
ones were read as negative ones.
For a photometric reading, the wells must be read at two
wavelengths (590 and 650 nm). The results were inter-
preted as the difference between the values of the two
readings. An example of interpretation of quantitative
results (optical density) is presented in Fig. 1. The assay
ended when the difference of absorbance of blank sample is
between 0.5 and 0.2. Cut-off point was set adding 0.4 units
to the blank absorbance values. Thus, samples with a
difference of absorbance equal or above those obtained for
the blank samples plus 0.4 will be positive.
Positive S590nm  S650nm  B590nm  B650nmð Þ þ 0:4
Negative S590nm  S650nm B590nm  B650nmð Þ þ 0:4
S sample absorbance
B blank absorbance
Determination of Limits of Detection
Limits of detection (LODs) for ten different antimicrobials
belonging to different families were determined: quinolones
(enrofloxacin, norfloxacin, sarafloxacin, marbofloxacin,
ciprofloxacin, danofloxacin, difloxacin, flumequine), tetra-
cyclines (doxycycline), beta-lactams (penicillin G), macrolides
(tylosin), sulphonamides (sulfathiazole) and aminoglicosides
(neomycin). For determination of sensitivity, dilutions were
obtained in bovine tissue fluid from antibiotic and sulphona-
mide standards. Spiked samples were prepared from antibiotic
and sulphonamide decimal dilutions immediately before every
assay.
Concentrations of inhibitors evaluated are shown in
Table 1. Samples were tested by ten replicate in every
assay. LODs for each antimicrobial was established as the
lower concentration that gave rise to a 100% of positive
results, according to a photometric evaluation.
Determination of Detection Capability
Solutions of quinolones were prepared in bovine tissue
fluid at the limit of sensitivity concentrations determined
previously. For each antimicrobial, aliquots of ten different
bovine tissue fluid containing the specified concentration
were tested.
Examination of Specificity
Ovine tissue fluid was obtained from 20 ovine muscle
samples from animals not treated with any antimicrobials
for 21 days prior to slaughter. These blank tissue samples
were tested in Equinox.
Ruggedness Testing—Effect of Species and Test Batch
Solutions of antimicrobials at detection capability (CCβ)
concentrations were prepared in bovine, ovine, poultry and
porcine tissue fluid for ruggedness testing. To evaluate the
effect of species, Equinox test was performed with
0
0.2
0.4
0.6
0.8
1
1.2
1 2 3 4 5 6 7 8 B C. O .
Fig. 1 Example of interpretation
of photometric reading. On every
assay, a blank sample (B) was
analysed and the cut-off point
(C. O.) was set adding 0.4 units
to the blank absorbance
values (difference of
absorbance B590 nm–B650 nm).
All samples tested in this assay
(1–8) were considered negative
since their absorbance values
(S590 nm–S650 nm) were below
the cut-off point
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antimicrobial solutions (n=5) diluted on tissue fluid from
different species. To evaluate the effect of kit batch,
antimicrobial solution (n=4) prepared in bovine tissue fluid
were tested in Equinox from four different batches.
Quantification of Antimicrobials in Incurred Tissue Samples
Incurred ovine tissue samples were obtained by dosing a
group of five 70-day-old Rasa Aragonesa lambs with
therapeutic doses of enrofloxacin administered through
feed. Another group of five lambs remained untreated as
blank samples. In order to achieve samples with high
concentration of residues, one animal from every group was
slaughtered 1, 2, 7 and 14 days after the start of the
treatment, subsequently quartered and quadriceps femoris
samples were individually packed, freezed (N2) and stored
at −20°C.With the purpose of evaluate Equinox performance,
these ovine tissue samples were analyzed both with Equinox
and with a confirmatory method. This confirmatory method
consisted of an adaptation of published method by Moats and
Romanowski (Moats and Romanowski 1998). In short, 5 g of
muscle were extracted with acetonitrile and hexane and the
filtrate was evaporated to a final volume of 5 mL. Two
millilitres of sample extract were injected in a preparative LC
with fraction collector equipment (BioRad). The fractionation
was carried out with a Supelcosil C18 (150×4.6 mm, 5 µm,
Supelco, USA) using a mobile phase 100% 0.01 M KH2PO4.
The HPLC system used for separation was Agilent
Technologies 1100 series equipped with a quaternary solvent
delivery system, an auto sampler, a column oven and a diode-
array detector. Data were captured with ChemStation software,
rev. B.01.03 (Agilent Technologies, USA). Chromatographic
separation was accomplished using a Kromasil 100 C18 (20×
4.6 mm, 5 µm) (Teknokroma, Spain) using a mobile phase
0.01 M KH2PO4 pH3.0: acetonitrile (90:10, v/v).
Results
Determination of LODs
Table 2 shows the limits of detection observed in Equinox
for enrofloxacin, norfloxacin, sarafloxacin, marbofloxacin,
ciprofloxacin, danofloxacin, difloxacin and flumequine
diluted in bovine muscle. Results were obtained both
according to a photometric measurement and through a
visual examination. Average absorbance value for each
sample and variation coefficients are included in the table.
Bovine tissue fluid samples containing 100, 200, 100, 100,
25, 200, 400 and 2,000 µg/kg of enrofloxacin, norfloxacin,
sarafloxacin, marbofloxacin, ciprofloxacin, danofloxacin,
difloxacin and flumequine respectively, were able to inhibit
the test Equinox. For other antimicrobials, Equinox
displayed a lower sensitivity, as it is shown in Table 3.
Doxycycline was detected at a concentration of 5,000 µg/kg
while 10,000 µg/kg of neomycin were able to inhibit the
test. However, Equinox could not detect tylosin, penicillin
G and sulfathiazole at 10,000, 5,000 and 10,000 µg/kg,
respectively. Results obtained through visual examination
were the same as those from a photometric measurement.
Determination of Detection Capability
To determine the CCβ for the investigated quinolones, 10
different blank bovine muscle samples fortified with
enrofloxacin (100 µg/kg), norfloxacin (200), sarafloxacin
(100), marbofloxacin (100), ciprofloxacin (25), danofloxacin
(200), difloxacin (400) and flumequine (2000) were analysed.
All the fortified samples were found to give a positive
response; therefore the CCβ corresponds with the determined
sensitivities included in Table 2.
Examination of Specificity
Analysis of 20 blank ovine muscle samples gave no false
positive results, indicating that matrix constituents do not
affect the specificity of Equinox (Fig. 2).
Ruggedness Testing—Effect of Species and Test Batch
The ruggedness of Equinox was examined evaluating the
effect of animal species and kit batch on the test results.
Table 4 summarizes the effect of animal species on the
limits of detection of Equinox test for several quinolones. A
positive response was observed for solutions of marbo-
Table 1 Concentrations of antimicrobials (diluted in bovine tissue
fluid) evaluated in Equinox and MRL UE for each compound in
bovine muscle (µg/kg)
Inhibitor µg/kg MRL
Enrofloxacin 50, 100, 200 100a
Norfloxacin 100, 200, 400
Ciprofloxacin 25, 50,100 100a
Sarafloxacin 50, 100, 200
Marbofloxacin 50, 100, 150 150
Danofloxacin 50, 100, 200 200
Difloxacin 200, 300, 400 400
Flumequine 500, 1,000, 2,000 200
Doxycycline 100, 1,000, 5,000 100
Tylosin 100, 1,000, 10,000 100
Sulfathiazole 100, 1,000, 10,000 100
Penicillin g 50, 500, 5,000 50
Neomycin 500, 5,000, 10,000 500
a Sum of enrofloxacin and ciprofloxacin
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floxacin at 100 µg/kg in all cases. However, the sensitivity
of Equinox for sarafloxacin in pork and beef was lower
than in lamb and chicken while the sensitivity for
enrofloxacin was lower in pork. Test batch was not found
to affect Equinox performance as it is shown in Table 5. In
all cases, the limits of detection of Equinox for enrofloxacin
and sarafloxacin were 100 µg/kg.
Quantification of Antimicrobials in Incurred Tissue Samples
Ovine tissue samples containing enrofloxacin and ciproflox-
acin were analyzed both with Equinox and with the confirma-
tory method (Table 6). Samples with 716/104 and 243/
140 µg/kg of enrofloxacin/ciprofloxacin, respectively, were
found to give a positive response in Equinox test. On the
contrary, samples containing 48/15 and 17/0 µg/kg of
enrofloxacin/ciprofloxacin were not able to inhibit Equinox.
Discussion
Enrofloxacin, ciprofloxacin, marbofloxacin, danofloxacin
and difloxacin were detected in bovine tissue fluid at levels
equal to the MRLs (100, 100, 150, 200 and 400 µg/kg).
Moreover, ≤100 µg/kg of marbofloxacin and ≤25 µg/kg of
ciprofloxacin showed an inhibitory effect on the test. Since
Photometric measurement Visual interpretation
AbsAV CV% Result T1 T2 T3 T4
NC 0.467 5.7 (−) (−) (−) (−) (−)
Cut-off point 0.867 (+)
Enrofloxacin
50 0.160 3.2 (−) (−) (−) (−) (−)
100 1.441 16.8 (+) (+) (+) (+) (+)
200 1.443 1.9 (+) (+) (+) (+) (+)
Norfloxacin
100 0.193 12.8 (−) (−) (−) (−) (−)
200 1.456 6.4 (+) (+) (+) (+) (+)
400 1.492 0.8 (+) (+) (+) (+) (+)
Sarafloxacin
50 0.173 16.2 (−) (−) (−) (−) (−)
100 1.461 5.2 (+) (+) (+) (+) (+)
200 1.465 1.9 (+) (+) (+) (+) (+)
Marbofloxacin
50 0.171 2.9 (−) (−) (−) (−) (−)
100 1.722 4.2 (+) (+) (+) (+) (+)
150 1.640 8.0 (+) (+) (+) (+) (+)
Ciprofloxacin
25 1.393 20.3 (+) (+) (+) (+) (+)
50 1.513 2.2 (+) (+) (+) (+) (+)
100 1.517 1.1 (+) (+) (+) (+) (+)
Danofloxacin
50 0.200 9.0 (−) (−) (−) (−) (−)
100 0.328 5.2 (−) (−) (−) (−) (−)
200 1.525 2.7 (+) (+) (+) (+) (+)
Difloxacin
200 0.177 6.5 (−) (−) (−) (−) (−)
300 1.201 19.8 (+) (+) (+) (+) (+)
400 1.591 2.6 (+) (+) (+) (+) (+)
Flumequine
500 0.180 19.3 (−) (−) (−) (−) (−)
1,000 0.452 6.1 (−) (−) (−) (−) (−)
2,000 1.479 4.1 (+) (+) (+) (+) (+)
Table 2 Sensitivity (µg/kg)
of Equinox for enrofloxacin,
norfloxacin, sarafloxacin
marbofloxacin, ciprofloxacin,
danofloxacin, difloxaicn and
flumequine diluted in bovine
muscle
Cut-off point is absAV NC + 0.4
AbsAV average of abs 590
and 650 nm for every well
inoculated with the sample or
standard, CV% coefficients of
variation, NC negative control
(blank bovine tissue fluid),
T1–T4 visual interpretation
result from four different
technicians, (+) 100% of
positive results, (−) 100%
of negative results
216 Food Anal. Methods (2011) 4:212–220
no MRLs for norfloxacin and sarafloxacin have been
established for bovine muscle, it is not possible to compare
the observed LODs with legal requirements. However, the
sensitivity showed by Equinox for norfloxacin and sara-
0
0.2
0.4
0.6
0.8
1
1.2
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Fig. 2 Effect of matrix constituents on Equinox specificity: analysis
of 20 blank ovine muscle samples
Table 4 Effect of animal species on sensitivity of Equinox for several
quinolones
µg/kg AbsAV CV%
Marbofloxacin
Pork 50 0.720 3
100 1.542 3.3
150 1.650 1.3
Beef 50 0.171 2.9
100 1.722 4.2
150 1.640 8.0
Lamb 50 0.153 10.8
100 1.511 1.7
150 1.421 11.2
Chicken 50 0.182 10.2
100 1.507 1.3
150 1.390 7.6
Enrofloxacin
Pork 50 1.582 1.1
100 1.665 1.9
200 1.705 1.1
Beef 50 0.160 3.2
100 1.441 16.8
200 1.443 1.9
Lamb 50 0.132 5
100 1.468 7.1
200 1.424 5.3
Chicken 50 0.121 6.9
100 1.519 5.9
200 1.502 3.8
Sarafloxacin
Pork 50 0.230 7.0
100 1.606 5.2
200 1.714 4.5
Beef 50 0.173 16.2
100 1.461 5.2
200 1.465 1.9
Lamb 50 0.189 4
100 0.399 6.7
200 1.411 8.2
Chicken 50 0.206 7.6
100 0.192 4.7
200 1.463 4.1
Negative control: pork (0.461±0.069), beef (0.476±0.024), lamb
(0.463±0.067), chicken (0.458±0.023). Cut-off point: pork (0.861),
beef (0.876), lamb (0.863), chicken (0.858)
AbsAV average of abs 590 and 950 nm for every well inoculated with
the sample or standard, CV% coefficients of variation
Table 3 Sensitivity (µg/kg) of Equinox for several antibiotics and
sulphonamides diluted in bovine muscle
Photometric measurement Visual interpretation
AbsAV CV Result T1 T2 T3 T4
NC 0.467 5.7 (−) (−) (−) (−) (−)
Cut-off point 0.867 (+)
Doxycycline
100 0.436 11.8 (−) (−) (−) (−) (−)
1,000 0.436 10.2 (−) (−) (−) (−) (−)
5,000 1.516 0.27 (+) (+) (+) (+) (+)
Neomycin
500 0.418 5.6 (−) (−) (−) (−) (−)
5,000 0.602 6.0 (−) (−) (−) (−) (−)
10,000 1.571 1.3 (+) (+) (+) (+) (+)
Tylosin
100 0.406 0.4 (−) (−) (−) (−) (−)
1,000 0.407 4.4 (−) (−) (−) (−) (−)
10,000 0.352 6.3 (−) (−) (−) (−) (−)
Penicillin G
50 0.407 8.9 (−) (−) (−) (−) (−)
500 0.409 3.1 (−) (−) (−) (−) (−)
5,000 0.327 5.5 (−) (−) (−) (−) (−)
Sulfathiazole
100 0.413 5.4 (−) (−) (−) (−) (−)
1,000 0.338 8.2 (−) (−) (−) (−) (−)
10,000 0.348 3.8 (−) (−) (−) (−) (−)
Cut-off point is AbsAV NC+0.4
AbsAV average of abs 590 and 950 nm for every well inoculated with
the sample or standard, CV% coefficients of variation, NC negative
control (blank bovine tissue fluid), T1–T4 visual interpretation result
from four different technicians, (+) 100% of positive results, (−) 100%
of negative results
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floxacin (200 and 100 µg/kg) in bovine tissue fluid are on
the order of established MRLs for other quinolones. For
that reason, Equinox sensitivity for norfloxacin and sara-
floxacin might be considered acceptable.
Sensitivity studies have been extensively conducted on
multiplate assays. A modification of the EC Four Plate
Method was developed by Currie et al. (Currie et al. 1998).
Minimum inhibitory concentration observed for ciproflox-
acin, enrofloxacin and sarafloxacin were 500 µg/kg using
standard solutions. A CCβ of ≤25, ≤50, ≤50 and ≤100 µg/kg
for enrofloxacin, danofloxacin, difloxacin and flumequine in
poultry muscle was reported with an improved microbial
screening assay based on the inhibition of Yersinia ruckeri
NCIMB 13282 (Pikkemaat et al. 2007). Myyniemi et al.
(Myllyniemi et al. 2000) evaluated the suitability of a
multiplate test based on inhibition of Bacillus subtilis
BGA. The authors concluded that enrofloxacin and
ciprofloxacin residues were not detected at MRL concen-
tration in bovine and porcine muscle samples. Other study
by the same author reported that a microbiological six-
plate method was able to detect a sum of enrofloxacin and
ciprofloxacin at 30 µg/kg (Myllyniemi et al. 2001). STAR
protocol was evaluated for antibiotic detection in muscle
(Fuselier et al. 2000). Slices of pork meat with 161 µg/kg
of enrofloxacin were detected by the plate inoculated with
E. coli ATCC 11303.
The suitability of E. coli for screening of different
quinolone residues was also determined using standard
solutions in media with different pH values (Okerman et al.
2007). The lowest limits of detection observed for
enrofloxacin, ciprofloxacin, marbofloxacin, norfloxacin,
sarafloxacin, danofloxacin, difloxacin and flumequine were
0.625, 1.25, 2.5, 5, 5, 1.25, 40 and 5 µg/kg, respectively. A
marked influence of medium pH on sensitivity was
observed for most of the quinolones evaluated. Moreover, it
has been showed previously that inhibition zones observed
with meat samples are likely to bemuch lower (Okerman et al.
1998). In contrast, other studies (Myllyniemi et al. 2000)
have concluded that inhibition zones were wider around
kidney samples containing antimicrobial residues than
around paper discs impregnated with standard solutions.
Differences between tissue matrices could explain this
disagreement since antimicrobial residue concentration in
matrices such as kidney was reported to be higher than
concentration in muscle samples. Therefore some authors
(Okerman et al. 2007) have concluded that it should be
advisable to use kidney rather than muscle samples as the
test material for analysis of residues in animals. However,
muscular antimicrobial concentration is more relevant for
consumer safety than kidney levels. Consequently, it would
be preferable to screen for antimicrobial residues in muscle,
despite some compounds could be detected at or about the
MRL in other tissues such as kidney.
Quinolones have also been detected by other methods
such as chromatographic methods, luminescence spectros-
copy or immunological tests. Chromatographic or lumines-
cence spectroscopy methods are intended for identification
and quantification of residues, and they are not considered a
Batch 1 Batch 2 Batch 3 Batch 4
AbsAV CV% AbsAV CV% AbsAV CV% AbsAV CV%
NC 0.467 5.7 0.416 10.3 0.348 10.1 0.409 5.4
Cut-off point 0.867 0.816 0.748 0.809
Enrofloxacin
50 0.160 3.2 0.175 5.9 0.188 3.1 0.186 8.2
100 1.441 16.8 1.446 4.7 1.513 2.7 1.341 4
200 1.443 1.9 1.486 3.9 1.490 8.2 1.358 4.2
Sarafloxacin
50 0.173 16.2 0.210 6 0.198 9.1 0.1965 8.9
100 1.461 5.2 1.429 4.2 1.450 3.9 1.2976 4.3
200 1.465 1.9 1.492 3.6 1.484 4.6 1.3598 3.5
Table 5 Limits of detection
(µg/kg) for enrofloxacin and
sarafloxacin in 4 batches
of Equinox
Negative control (blank
bovine tissue fluid)
Enrofloxacin (µg/kg) Ciprofloxacin (µg/kg) Equinox
Sample 1 716 104 (+)
Sample 2 243 140 (+)
Sample 3 48 15 (−)
Sample 4 17 0 (−)
Table 6 Quantification of
enrofloxacin and ciprofloxacin
in incurred ovine tissue
samples by a confirmation
method: comparison with
Equinox results
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first choice for screening a large number of samples since
they are specific, more labour-intensive and more expensive
than microbial tests (Myllyniemi et al. 2000). Rose at al.
(Rose et al. 1998) optimized and validated a multi-residue
procedure, with a limit of determination of 10 µg/kg for
ciprofloxacin, enrofloxacin, norfloxacin, sarafloxacin and
marbofloxacin and 5 µg/kg for danofloxacin. A published
terbium-sensitized luminescence method showed a limit of
detection for ciprofloxacin and enrofloxacin below 1 µg/L
(Hernández-Arteseros et al. 1998). Nevertheless, the sensi-
tivity depended on the matrix composition and the limits of
detection were higher when analyzing trout or chicken tissue,
ranging from 2.7 to 3.8 µg/kg. Immunological methods are
generally used for screening and post-screening, since they are
specific for one group of antimicrobials. Enzyme immunoas-
say kits for the quantitative analysis of quinolones in several
matrices have been commercialised by different manufac-
turers. Generally, these kits have lower limits of detection than
microbial methods but cross reactivities between the different
quinolones detected are not optimal in most cases (Tittlemier et
al. 2008; Scortichini et al. 2009). Antibodies used in ELISA
tests for detection of quinolones have shown cross-reactivity
values lower than 10% against several evaluated quinolones.
Equinox was found to be less sensitive for other antimi-
crobial groups. Doxycycline, tylosin, neomycin, penicillin G
and sulfathiazole were not detected at concentrations ten times
higher than MRLs. Furthermore, Equinox could not detect
tylosin, penicillin G and sulfathiazole at concentrations even
100 times above MRLs. In all cases, concentration of
antimicrobials able to inhibit Equinox were well above
reported limits of detection in broad-spectrum screening tests.
However, Gaudin et al observed an inhibitory effect of several
cephalosporins on E. coli plates (Gaudin et al. 2004). None
of the antimicrobials evaluated, except for tested quinolones,
was detected in Equinox at MRL concentration. Moreover,
results observed when spiking muscle tissue with quinolones
or other groups of antimicrobials were in agreement with
data from HPLC results.
All the fortified samples with enrofloxacin (100 µg/kg),
norfloxacin (200), sarafloxacin (100), marbofloxacin (100),
ciprofloxacin (25), danofloxacin (200), difloxacin (400) and
flumequine (2000) gave a positive response in Equinox.
Therefore, the detection capability for every evaluated
quinolone was found to correspond with the sensitivities
obtained in Table 2. European legislation requires that the
CCβ of screening tests is equal or below the MRL. Thus,
Equinox might be approved for official surveys, at least for
enrofloxacin, ciprofloxacin, marbofloxacin, danofloxacin
and difloxacin. Analysis of 20 blank ovine muscle samples
gave no false positive results. These data suggest that
matrix constituents do not affect the specificity of Equinox.
Equinox was tested for ruggedness evaluating effect of
animal species and test batch according to EU requirements
(Anonymous 2000). Animal species were not found to
affect Equinox sensitivity for marbofloxacin, since 100 µg/kg
gave rise to a positive result in porcine, bovine and ovine
muscle. Consequently, concentrations of marbofloxacin at
MRL levels would be detected by Equinox in all meat species.
In contrast, the sensitivity of Equinox for enrofloxacin was
lower in porcine muscle, while sarafloxacin showed higher
limits of detection in ovine and chicken. Nevertheless,
differences observed could be more influenced by individual
factors than by animal species. Supplementary experiments
would be necessary to conclude if Equinox sensitivity is
affected by animal species. Previous studies reported that
performance of other commercial screening tests were not
affected by animal species while microbial multiplate methods
are considered to be more influenced by kind of samples
(Myllyniemi et al. 2000; Okerman et al. 1998). As it is shown
in Table 5, sensitivity for enrofloxacin and sarafloxacin in
four batches of Equinox was 100 µg/kg. Thus, on the basis
of the results it could be concluded that the limit of detection
for enrofloxacin and sarafloxacin were not affected by kit
batch. Further investigations might be necessary to evaluate
the effect of batch kit on sensitivity for other quinolones and
even to other antimicrobials.
One of the most critical points when screening for
antimicrobial residues is the reading of the results. Positive
results are shown in multiplate assays by measuring the
inhibition zones observed around samples. Nonetheless,
these results could be difficult to interpret since these
inhibition zones might be influenced by different parame-
ters, like inoculum concentration, agar depth, temperature
of incubation or batch preparation. Moreover, high percentage
of false-positive results is often associated with the use of
microbial diffusion methods (Pikkemaat et al. 2007). As it is
shown in Tables 2 and 3, there were a total correspondence
between the results obtained through a photometric mea-
surement and those ones from a visual interpretation.
Therefore, a photometric reading might be applied to
Equinox, avoiding variations due to visual reading made by
different technicians or performed over different days.
It is assumed that multiplate methods using more than one
indicator microorganism enable to target a broader range or
antimicrobial residues. Therefore, and considering Equinox
sensitivity pattern for quinolones and other antimicrobials, the
test might be suitable for monitoring meat samples in
situations where the presence of residues of quinolones can
be expected. In contrast, it should be combined with a broad
spectrum test unable to detect quinolones at violative levels in
foods (i.e. based on G. stearothermophilus) for screening of
unknown muscle samples. Performance of Equinox along
with other broad spectrum method (i.e. Explorer®, ZEU-
INMUNOTEC, Spain or Premitest®, DSM, Netherlands)
would enable a virtually complete plan for the screening of
antimicrobials in muscle. Thus, a positive result only in
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Equinox might suggest that the sample contains quinolones
residues above Equinox LODs. An inhibition observed in
both tests might be related to a high concentration of
antimicrobial residues (able to inhibit even Equinox) or to
the presence of one or more quinolones together with one or
more antibiotic/sulfonamides.
Conclusion
The Equinox test was found to detect several quinolones
(enrofloxacin, ciprofloxacin, marbofloxacin, norfloxacin, sara-
floxacin, danofloxacin, difloxacin and flumequine) in the
muscles of different animal species (bovine, ovine, porcine
and poultry). Except for flumequine, the limits of detection
observed for these quinolones were below or on the order of
established MRLs. Furthermore, Equinox exhibited a much
lower sensitivity for other groups of antimicrobials (doxycy-
cline, tylosin, neomycin, penicillin G, sulfathiazole). However,
sensitivity of Equinox to cephalosporins should be investigat-
ed. The results obtained in this study prove that Equinox is fit
for purpose as a qualitative screening test for quinolone
residues (EU commission decision 2002/657/EC). Thus,
Equinox test should be considered a useful tool when screening
for quinolone residues. However, it should be combined with
other methods for screening of unknown samples. Other
advantage of the kit is that the results can be obtained through
a photometric reading, avoiding variations due to subjective
visual interpretation. Moreover, Equinox could be easily
automated enabling a simultaneous analysis of large numbers
of samples.
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